Company Pardes Biosciences, Inc.
Equities
PRDS
US69945Q1058
Biotechnology & Medical Research
Business Summary
Number of employees: 57
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 60 | 20-12-31 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 23-08-29 |
Chief Operating Officer | - | - | |
Ann D. Kwong
CTO | Chief Tech/Sci/R&D Officer | - | - |
Patrick O’Brien
IRC | Investor Relations Contact | - | - |
Dave Kuo
HRO | Human Resources Officer | - | - |
Sean P. Brusky
PRN | Corporate Officer/Principal | 47 | 21-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 60 | 20-12-31 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 23-08-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 63,331,613 | 36,906,514 ( 58.28 %) | 1,319,857 ( 2.084 %) | 58.28 % |
Company contact information
Pardes Biosciences, Inc.
2173 Salk Avenue Suite 250
92008, Carlsbad
+
Sector
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |